Comments

Spero Therapeutics Stock News

SPRONASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.6820
At close: May 28 EDT
$2.39
1.71250.44%
Pre-Market: 8:25 AM EDT
Why is it moving?
Spero Therapeutics shares are trading higher after the company and GSK announced the Phase 3 study of tebipenem HBr met its primary endpoint and will stop early for efficacy.
Spero Therapeutics (SPRO) Forecast

News

EarningsSpero Therapeutics (SPRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Latest Spero Therapeutics Stock News | NASDAQ:SPRO | Benzinga

Get the latest news on Spero Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Spero Therapeutics performance

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved